Capstone Therapeutics: The Drugless Drug Company

Woke up this morning and was greeted with this headline: "Capstone Therapeutics Announces Operational Update via GlobeNewswire at 08:00am EST". Time to hold my breath while click this hyperlink: Capstone Therapeutics Announces Operational Update

In a nutshell, Capstone is a drugless drug company. From the press release... "Capstone will cease clinical development of AZX100..." and "[The company] will cease all activities related to the development of TP508..." and because of legal reasons they cannot distribute cash to shareholders. The company's current cash position was not contained in the press release. [Qui Tam cases are lawsuits filed on behalf of the government by private citizens for false claims or fraud. via AttorneyPages.com]

CAPS.PK closed at $0.27 on 02012.01.19.